NPI registry status
Active
2026 NPPES data Urology Physician NPI 1790769016 M.D.
Verify on CMS → Martin Bastuba, M.D.
Urology Physician in San Diego, California.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 13,606 in Urology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
338
Medicare Part D claims · 95 beneficiaries · Urology Physician avg: 1K
Generic prescribing
95%
generic claims · 5% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$15.56
1 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Martin Bastuba, M.D. filed 338 Medicare Part D claims in 2024 as a Urology Physician in San Diego, California, prescribing 95% generic.
- 338
- Part D claims, 2024
- 95%
- generic prescribing
- $15.56
- industry payments (Sunshine Act)
- ≥56th
- pct by Part D claim volume (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Martin Bastuba, M.D.
Federal records show an active NPI with Medicare Part D prescribing activity — verifiable registry data, not a proprietary rating.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1790769016), first enumerated 11/30/2005.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 338 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
Board certification signal
Practices in an ABMS-board-eligible specialty; board certification not confirmed in federal records.
- Reported
Industry payment transparency
$15.56 in reported industry payments (1 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- State context
State board disciplinary context
California statewide board action statistics are published annually — these figures describe aggregate state activity, not Martin Bastuba, M.D.'s individual license status. Verify directly with the state medical board.
Source: MBC annual report 2023
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1790769016 · Urology Physician
NPI-10 · ENUM-LEGACY · TAX-MID · RX-LIGHT · BOOK-LIGHT · PHOTO-ENUM
- NPI-10 1790769016
- ENUM-LEGACY 2005
- TAX-MID 14K Urology Physician
- RX-LIGHT 338
- BOOK-LIGHT 1,421 in California
- PHOTO-ENUM Richard Bihrle · 2005
Martin Bastuba, M.D.'s Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2024, across all CMS prescribers nationally
338 ≥ 56th percentile 56% of 1,416,883 prescribers are in lower value bands
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.
Source CMS Medicare Part D Prescriber Public Use File · 2024
◑
Board-eligible specialty (heuristic, not verified)
Martin Bastuba, M.D. practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Martin Bastuba, M.D.?
Quality data not reportedPrimary specialty
Urology Physician
Medicare Part D claims
338 75% vs specialty avg
Specialty distribution in California
How Urology Physician compares to other specialties among California providers
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Urology Physician. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1790769016 |
|---|---|
| Specialty | Urology Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 11/30/2005 |
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Martin Bastuba, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$16
Largest payer
Antares Pharma, Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - California MBC 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 - they are NOT specific to Martin Bastuba, M.D.. To verify Martin Bastuba, M.D.'s current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases
MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Generic-heavy
Martin Bastuba, M.D. - brand share 5.0%
Urology Physician average
5% brand-name claims vs 95% generic, on 338 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
338
Total Claims
$21K
Total Drug Cost
95
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 471.5
- Total Day Supply
- 12,330
- Brand vs Generic
- 5% brand / 95% generic
- Brand Drug Cost
- $6K
- Generic Drug Cost
- $14K
- Opioid Claims
- 14 (4.1% rate)
- Antibiotic Claims
- 53
Patient Demographics
- Average Patient Age
- 74.2 years
- Avg HCC Risk Score
- 1.18
- Gender Split
- 16% female / 84% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Martin Bastuba, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2024
- Tamsulosin Hcl
Tamsulosin Hcl
99 claims
- Testosterone Cypio… 38
Testosterone Cypionate
38 claims
- Alfuzosin Hcl Er 23
Alfuzosin Hcl Er
23 claims
- Finasteride 21
Finasteride
21 claims
- Testosterone 19
Testosterone
19 claims
- Anastrozole 15
Anastrozole
15 claims
- Sulfamethoxazole-T… 15
Sulfamethoxazole-Trimethoprim
15 claims
- Hydrocodone-Acetam… 12
Hydrocodone-Acetaminophen
12 claims
| Drug | Claims |
|---|---|
| Tamsulosin Hcl | 99 |
| Testosterone Cypionate | 38 |
| Alfuzosin Hcl Er Alfuzosin Hcl | 23 |
| Finasteride | 21 |
| Testosterone | 19 |
| Anastrozole | 15 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 15 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 12 |
| Solifenacin Succinate | 12 |
| Cephalexin | 11 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Urology Physician Overview
How Martin Bastuba, M.D. fits within the Urology Physician landscape nationally.
13,606
Urology Physician Providers in US
54
States with Urology Physician
1,354
Avg Claims per Provider
Martin Bastuba, M.D.'s 338 claims are below the specialty average of 1,354.
Nationwide Urology Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Bastuba, both outside California so the neighborhoods are not geographic containment.
Same NPPES enumeration year (2005)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Urology Physician Providers in California
Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as Bastuba.
One of 1,421 Urology Physician providers enrolled in California, 5 are shown here.
Dr. David Aaronson
MD
Oakland, CA
Dr. Jason Abber
MD
Panorama City, CA
Dr. Marc Abboud
MD
Los Alamitos, CA
George Abdelsayed
Anaheim, CA
Garen Abedi
Downey, CA
Compare Urology Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Martin Bastuba, M.D.'s specialty? ▼
Martin Bastuba, M.D. specializes in Urology Physician and practices in San Diego, California. Credentials: M.D..
How much does Martin Bastuba, M.D. prescribe under Medicare Part D? ▼
In 2024, Martin Bastuba, M.D. wrote 338 Medicare Part D claims totaling $21K in drug costs for 95 beneficiaries.
Where is Martin Bastuba, M.D. located? ▼
Martin Bastuba, M.D. is located at 6699 ALVARADO RD, San Diego, CA, 92120. Phone: (619) 286-3520.
What is Martin Bastuba, M.D.'s NPI number? ▼
Martin Bastuba, M.D.'s National Provider Identifier (NPI) is 1790769016, issued on 11/30/2005.
Does Martin Bastuba, M.D. prescribe more brand-name or generic drugs? ▼
Martin Bastuba, M.D.'s prescribing is 5% brand-name and 95% generic drugs by claim count, with $6K in brand drug costs.
Does Martin Bastuba, M.D. prescribe opioids? ▼
Yes, Martin Bastuba, M.D. had 14 opioid claims in 2024 with an opioid prescribing rate of 4.1%.
How many Urology Physician providers are there in the US? ▼
There are 13,606 Urology Physician providers across 54 states in the US. The average Urology Physician provider writes 1,354 Medicare Part D claims per year.
What drugs does Martin Bastuba, M.D. prescribe most often? ▼
Based on 2024 Medicare Part D data, Martin Bastuba, M.D.'s most frequently prescribed drugs include Tamsulosin Hcl, Testosterone Cypionate, Alfuzosin Hcl Er. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Martin Bastuba, M.D. accept Medicare? ▼
Martin Bastuba, M.D. appears in CMS Medicare data with 338 Part D claims and 95 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Martin Bastuba, M.D.'s credentials? ▼
Martin Bastuba, M.D.'s NPI is 1790769016 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.